These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 184610)

  • 21. [Metabolism and clinical significance of lipoprotein Lp(a) (author's transl)].
    Krempler F
    Acta Med Austriaca; 1980; 7(4-5):101-3. PubMed ID: 6454320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new and simplified method for the detection of LP-X, a cholestasis specific lipoprotein].
    Wieland H; Seidel D
    Dtsch Med Wochenschr; 1973 Aug; 98(31):1474-5. PubMed ID: 4352438
    [No Abstract]   [Full Text] [Related]  

  • 23. Depletion of high-density lipoprotein and appearance of triglyceride-rich low-density lipoprotein in a Japanese patient with FIC1 deficiency manifesting benign recurrent intrahepatic cholestasis.
    Nagasaka H; Chiba H; Hui SP; Takikawa H; Miida T; Takayanagi M; Yorifuji T; Hasegawa M; Ota A; Hirano K; Kikuchi H; Tsukahara H; Kobayashi K
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):96-105. PubMed ID: 17592371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [LP-X in the first month of life (author's transl)].
    Lachmann D; Eder G
    Padiatr Padol; 1977; 12(4):334-8. PubMed ID: 904943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.
    Watanabe M
    Acta Med Okayama; 1979 Aug; 33(4):269-85. PubMed ID: 227230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple lipoprotein and electrolyte laboratory artifacts caused by lipoprotein X in obstructive biliary cholestasis secondary to pancreatic cancer.
    Sivakumar T; Chaidarun S; Lee HK; Cervinski M; Comi R
    J Clin Lipidol; 2011; 5(4):324-8. PubMed ID: 21784379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the structure and metabolism of lipoprotein-X (LP-X), the abnormal plasmalipoprotein in cholestasis (author's transl)].
    Seidel D
    Klin Wochenschr; 1977 Jul; 55(13):611-23. PubMed ID: 197298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of lipoprotein-X and serum cholinesterase in preoperative diagnosis of obstructive jaundice].
    Prexl HJ; Petek W
    Chirurg; 1973 Jul; 44(7):310-3. PubMed ID: 4353807
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnostic value of lipoprotein X (Lp-X) in the diagnosis of cholestasis].
    Wróblewska R; Kaszubowski P; Wysocki J
    Wiad Lek; 1977 Dec; 30(24):1883-5. PubMed ID: 605615
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of fractional and subfractional blood lipoprotein compositions with small angle X-ray scattering (a comparison with a biochemical method)].
    Tuzikov FV; Ragino IuI; Tuzikova NA; Ivanova MV; Galimov RV; Nikitin IuP
    Vopr Med Khim; 2002; 48(1):84-93. PubMed ID: 12068501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preliminary evaluation of lipoprotein X (lp-X) detection in the serum in obstructive jaundice].
    Umińska H; Palynyczko Z
    Pol Przegl Chir; 1975 Oct; 47(10):1195-200. PubMed ID: 171636
    [No Abstract]   [Full Text] [Related]  

  • 32. [Semiquantitative determination of lipoprotein X (Lp-X): its usefulness in differential diagnosis of jaundice].
    Alegre B; Carrasco D; Breto MD; Gras M; Berenguer J
    Rev Clin Esp; 1976 Oct; 143(1):79-81. PubMed ID: 188081
    [No Abstract]   [Full Text] [Related]  

  • 33. The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection.
    Neff GW; Shire N; Ruiz P; O'Brien C; Garcia M; Dela Garza J; Rudich SR; Reddy KR
    Transplant Proc; 2005 Dec; 37(10):4397-402. PubMed ID: 16387130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic efficacy of echography in cholestasis.
    Baddeley H; Hart J; Outridge D; Boyd P; Powell L
    Diagn Imaging; 1983; 52(6):316-22. PubMed ID: 6641473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histological changes in liver tissue in cholestasis].
    Machnik G
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():7-10. PubMed ID: 7483720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipoprotein-X (LP-X): a new test for the diagnosis of cholestasis].
    Mast A; Van Gijsegem D; Dero M; Barbier F
    Tijdschr Gastroenterol; 1975; 18(5):293-302. PubMed ID: 176750
    [No Abstract]   [Full Text] [Related]  

  • 37. [The prognostic value of serochemical cholestasis parameters in liver cirrhosis].
    Rink C; Haerting J; Nilius R
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():67-70. PubMed ID: 7483719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quality rating of MR-cholangiopancreatography with oral application of iron oxide particles].
    Lorenzen M; Wedegärtner U; Fiehler J; Adam G
    Rofo; 2003 Jul; 175(7):936-41. PubMed ID: 12847648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.
    Habib SS; Aslam M
    Saudi Med J; 2003 Jun; 24(6):647-51. PubMed ID: 12847596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.